Cargando…

Recurrent colon perforation after discontinuation of bevacizumab for ovarian cancer

Bevacizumab (Bev) is an antiangiogenic drug used to treat various malignances, including ovarian cancer (OC). Bev is generally well-tolerated; however, it has a characteristic toxicity profile. In particular, gastrointestinal perforation (GIP) is a rare but serious side effect that can be lethal. A...

Descripción completa

Detalles Bibliográficos
Autores principales:	Nonaka, Michiko, Sato, Seiya, Osaku, Daiken, Sawada, Mayumi, Kudoh, Akiko, Chikumi, Jun, Sato, Shinya, Oishi, Tetsuro, Harada, Tasuku
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2018
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6116855/ https://www.ncbi.nlm.nih.gov/pubmed/30175211 http://dx.doi.org/10.1016/j.gore.2018.08.005

Ejemplares similares

Efficacy of panniculectomy-combined surgery in superobese patients with endometrial cancer: A case report and literature review
por: Okawa, Masayo, et al.
Publicado: (2020)

Differential expression of estrogen receptor subtypes in ovarian high‐grade serous carcinoma and clear cell carcinoma
por: Osaku, Daiken, et al.
Publicado: (2021)

Retroperitoneal Endometrioid Carcinoma Arising from Ureteral Endometriosis
por: Osaku, Daiken, et al.
Publicado: (2019)

Calcified Ovarian Fibromas Complicated with Basal Cell Nevus Syndrome
por: Osaku, Daiken, et al.
Publicado: (2021)

D-dimer level significance for deep vein thrombosis screening in the third trimester: a retrospective study
por: Miyamoto, Keisuke, et al.
Publicado: (2022)

AMIGO2 expression as a predictor of recurrence in cervical cancer with intermediate risk
por: Iida, Yuki, et al.
Publicado: (2023)

Progression after discontinuation of bevacizumab in the first-line treatment of ovarian cancer
por: Nakai, Hidekatsu, et al.
Publicado: (2023)

Bevacizumab‐associated intestinal perforation and perioperative complications in patients receiving bevacizumab
por: Yoshimoto, Toshiaki, et al.
Publicado: (2020)

A New Therapeutic Strategy for Recurrent Ovarian Cancer―Bevacizumab beyond Progressive Disease
por: Shoji, Tadahiro, et al.
Publicado: (2019)

Post-bevacizumab Clinical Outcomes and the Impact of Early Discontinuation of Bevacizumab in Patients with Recurrent Malignant Glioma
por: Cha, Yongjun, et al.
Publicado: (2017)

Exploration of the recurrence in radiation brain necrosis after bevacizumab discontinuation
por: Zhuang, Hongqing, et al.
Publicado: (2016)

Spontaneous massive duodenal perforation after ovarian cancer treatment with bevacizumab
por: Karanikas, Michael, et al.
Publicado: (2020)

lncRNA UCA1-Mediated Cdc42 Signaling Promotes Oncolytic Vaccinia Virus Cell-to-Cell Spread in Ovarian Cancer
por: Horita, Kosuke, et al.
Publicado: (2019)

Acute anterior uveitis after discontinuation of tocilizumab in a patient with rheumatoid arthritis
por: Sato, Tomohito, et al.
Publicado: (2014)

Case of endophthalmitis following intravitreal injections of bevacizumab
por: Komori, Shinya, et al.
Publicado: (2010)

Bowel Perforation in the Emergency Department Related to Bevacizumab Therapy and Recurrent Ovarian Cancer
por: Ostby, Stuart A., et al.
Publicado: (2020)

Intestinal Perforation: A Rare Complication of Treatment With Bevacizumab
por: Adhikari, Ramesh, et al.
Publicado: (2021)

Impacts of trans‐anal tube placement in patients with sigmoid colon cancer: Risk verification analysis using inverse probability weighting analysis
por: Tominaga, Tetsuro, et al.
Publicado: (2022)

A case of primary breast angiosarcoma with multiple discontinuous small lesions
por: Sasahara, Asako, et al.
Publicado: (2019)

Intestinal Perforation due to Neutropenic Enterocolitis in a Patient Treated with Bevacizumab for Ovarian Cancer
por: Sasaki, Akinori, et al.
Publicado: (2020)

Transverse colon perforation in the mediastinum after esophagectomy: a case report
por: Konno-Kumagai, Takuro, et al.
Publicado: (2020)

Spontaneous Healing of Corneal Perforation after Temporary Discontinuation of Erlotinib Treatment
por: Morishige, Naoyuki, et al.
Publicado: (2014)

Reconstructing Discontinuous Facial Defects with Simultaneous Ulnar Perforator Free Flaps
por: Thomas, Carissa M., et al.
Publicado: (2017)

Discontinuous Schedule of Bevacizumab in Colorectal Cancer Induces Accelerated Tumor Growth and Phenotypic Changes
por: Becherirat, Selma, et al.
Publicado: (2018)

Baffling perforation of the colon
por: Losanoff, Julian E., et al.
Publicado: (2010)

IVC Filter Perforation Through the Duodenum
por: Hongo, Takashi, et al.
Publicado: (2019)

Efficacy and safety of standard of care with/without bevacizumab for platinum‐resistant ovarian/fallopian tube/peritoneal cancer previously treated with bevacizumab: The Japanese Gynecologic Oncology Group study JGOG3023
por: Shoji, Tadahiro, et al.
Publicado: (2021)

Sigmoid colon diverticula perforation associated with sevelamer hydrochloride administration: A case report
por: Yamaguchi, Takahisa, et al.
Publicado: (2016)

Ipilimumab-induced colonic perforation
por: Burdine, Lyle, et al.
Publicado: (2014)

Stercoral Perforation of the Colon in Pregnancy
por: Atkinson, Andrew L., et al.
Publicado: (2010)

Idiopathic Neonatal Colonic Perforation
por: Demir, Nihat, et al.
Publicado: (2014)

Gastrointestinal Perforation With an Intraluminal Stent and Bevacizumab use in Advanced Metastatic Colorectal Cancer
por: Akeel, Nouf, et al.
Publicado: (2021)

A Case of Basal Cell Adenoma of the Upper Lip
por: Kudoh, Masanori, et al.
Publicado: (2014)

Massive odontoameloblastoma arising in the maxilla: a case report
por: Kudoh, Masanori, et al.
Publicado: (2015)

Colonic Perforation in Polyarteritis Nodosa With Concurrent Perforated Sigmoid Diverticulitis
por: Leung, Christopher, et al.
Publicado: (2022)

Why do women discontinue contraception and what are the post-discontinuation outcomes? Evidence from the Arusha Region, Tanzania
por: Sato, Ryoko, et al.
Publicado: (2020)

Bevacizumab-Induced Reversible Thrombocytopenia in a Patient with Adenocarcinoma of Colon: Rare Adverse Effect of Bevacizumab
por: Kumar, Jeevan, et al.
Publicado: (2012)

DIFFERENTIAL EXPRESSION OF CARCINOEMBRYONIC ANTIGEN AND NONSPECIFIC CROSSREACTING ANTIGEN GENES IN HUMAN COLON ADENOCARCINOMAS AND NORMAL COLON MUCOSA
por: Sato, Chieko, et al.
Publicado: (1988)

Colonic Perforation Secondary to Gallstone Impaction in the Sigmoid Colon
por: Gavriilidis, Paschalis, et al.
Publicado: (2023)

Association of online activities with obstetrics and gynecology specialty choice: a nationwide online survey
por: Maeda, Yuto, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_dtkbik9d275109rr68t32gq4qj